FormWeb • canagliflozin

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

canagliflozin

canagliflozin

Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Invokana	TABLET, ORAL	100 mg, 300 mg

VIEW MORE Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
CLASS

Comments:

Invokana medication guide

Automatic renal adjustment to 100 mg daily if eGFR is between 45-60 mL/min. If eGFR less than 45 mL/min, contact the physician to discuss discontinuation and alternative therapy options.

Reviewed: May 28, 2013 (Invokana)

Last updated: Dec. 27, 2017

Black Box Warning: Lower Limb Ampution

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.